Redwood Shores, Calif.-based Oracle Corp. will acquire clinical trials management software vendor Phase Forward Inc. for $685 million.

Based in Waltham, Mass., Phase Forward's applications cover the clinical trials process from study initiation and FDA submission through post-marketing studies. The applications have been used in over 10,000 clinical trials involving more than 1 million trial study participants at more than 300 life sciences companies, medical device firms, regulatory agencies and public health organizations, according to the company.

Publicly traded Phase Forward in 2009 had revenue of $213.3 million, up 25 percent from the previous year. Net income fell 42 percent to $8 million, with significantly higher expenses during 2009 across the sales and marketing, research and development, and general and administrative areas.

Upon closure of the acquisition, Phase Forward will be part of Oracle's Health Sciences division. More information is available at oracle.com and phaseforward.com.

--Joseph Goedert

 

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access